drugs

A Partial Approval for Amgen's Osteoporosis Drug - New York Times
dBTechnoA Partial Approval for Amgen's Osteoporosis DrugNew York TimesAmgen's new bone drug, the company's best hope for future growth, won a partial endorsement Thursday from a federal advisory committee ...Amgen presses US panel to endorse key bone drugReutersUS FDA panel partly backs Amgen bone drugForbesAmgen's Bone-Loss Drug Faces Marketing HurdlesBusinessWeekWall Street Journal�-RTT News�-PR Newswire (press release)all 749 news articles��